Timber Hill’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-20,200	Closed	-$2.45M	–	2355
2017 Q1	$2.45M	Sell	20,200 -800	-4%	-$103K	0.28%	618
2016 Q4	$2.57M	Sell	21,000 -14,600	-41%	-$1.79M	0.27%	776
2016 Q3	$4.36M	Sell	35,600 -53,600	-60%	-$6.9M	0.42%	522
2016 Q2	$10.4M	Buy	89,200 +33,300	+60%	+$4.72M	0.87%	310
2016 Q1	$7.78M	Buy	55,900 +17,600	+46%	+$2.58M	0.61%	381
2015 Q4	$7.31M	Sell	38,300 -21,000	-35%	-$3.67M	0.76%	413
2015 Q3	$9.27M	Sell	59,300 -22,700	-28%	-$4.14M	0.98%	346
2015 Q2	$14.8M	Buy	82,000 +16,200	+25%	+$2.8M	1.13%	255
2015 Q1	$11.4M	Sell	65,800 -1,500	-2%	-$272K	1.11%	305
2014 Q4	$12.5M	Buy	67,300 +15,700	+30%	+$2.91M	0.77%	287
2014 Q3	$8.56M	Buy	51,600 +8,600	+20%	+$1.41M	0.81%	397
2014 Q2	$6.72M	Sell	43,000 -24,400	-36%	-$3.85M	0.67%	487
2014 Q1	$10.3M	Buy	67,400 +21,800	+48%	+$3.47M	1.27%	341
2013 Q4	$6.06M	Sell	45,600 -1,600	-3%	-$192K	0.49%	665
2013 Q3	$5.48M	Sell	47,200 -15,300	-24%	-$1.68M	0.44%	797
2013 Q2	$5.76M	Buy	+62,500	New	+$6.02M	0.59%	741